Non-HFE hemochromatosis: Pathophysiological and diagnostic aspects. - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Clinics and Research in Hepatology and Gastroenterology Année : 2013

Non-HFE hemochromatosis: Pathophysiological and diagnostic aspects.

Résumé

Rare genetic iron overload diseases are an evolving field due to major advances in genetics and molecular biology. Genetic iron overload has long been confined to the classical type 1 hemochromatosis related to the HFE C282Y mutation. Breakthroughs in the understanding of iron metabolism biology and molecular mechanisms led to the discovery of new genes and subsequently, new types of hemochromatosis. To date, four types of hemochromatosis have been identified: HFE-related or type1 hemochromatosis, the most frequent form in Caucasians, and four rare types, named type 2 (A and B) hemochromatosis (juvenile hemochromatosis due to hemojuvelin and hepcidin mutation), type 3 hemochromatosis (related to transferrin receptor 2 mutation), and type 4 (A and B) hemochromatosis (ferroportin disease). The diagnosis relies on the comprehension of the involved physiological defect that can now be explored by biological and imaging tools, which allow non-invasive assessment of iron metabolism. A multidisciplinary approach is essential to support the physicians in the diagnosis and management of those rare diseases.
Fichier principal
Vignette du fichier
Hemochromatosis_CRHG-accepted.pdf (267.48 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-00925741 , version 1 (08-01-2014)

Identifiants

Citer

Edouard Bardou-Jacquet, Zeineb Ben Ali, Marie-Pascale Beaumont-Epinette, Olivier Loréal, Anne-Marie Jouanolle, et al.. Non-HFE hemochromatosis: Pathophysiological and diagnostic aspects.. Clinics and Research in Hepatology and Gastroenterology, 2013, 38 (2), pp.143-154. ⟨10.1016/j.clinre.2013.11.003⟩. ⟨hal-00925741⟩
1413 Consultations
1649 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More